Hints and tips:
...BioNTech and Pfizer have described a similar patent filed in the US as “unimaginably broad” in American proceedings....
...“In the early days, people underestimated ‘Bayo’,” said Kenneth Chenault, former CEO of American Express, and a close friend of Ogunlesi since both were at Harvard Law School....
...One example comes from a comparison of the disclosures by WuXi Biologics, a pharmaceutical company that listed in 2017, and WuXi XDC, a unit it spun off and listed last year....
...Michael Sklar, develops “nonstandard trial designs”, which seems to basically use maths to speed up the process of developing pharmaceutical studies....
...Let us know what you think at imani.moise@ft.com and sid.v@ft.com. A programming note: FintechFT will take a one-week break in observance of the Easter holiday. The next issue will be April 25....
...The US drugmaker and its German partner are hoping to build on their success with the Covid-19 vaccine, with BioNTech providing its proprietary mRNA technology and Pfizer contributing its antigen research...
...PlantForm, a Canadian biotech company, and Sydney-based NeuClone Pharmaceuticals are already working with partners in Brazil and India to launch “biosimilars” that are almost identical to Keytruda....
...His mother was a Time Inc executive, and his father a Washington diplomat who worked for the US Agency for International Development....
...Mr Frazier is one of only a handful of African-American chief executives of Fortune 500 companies, and spoke out against the killing of George Floyd last year....
...Write to the FintechFT team at imani.moise@ft.com and sid.v@ft.com. You can build it, but will they come?...
...The application will be reviewed by the FDA just months after a similar request by Pfizer and its partner BioNTech sparked a contentious debate among officials over whether boosters were needed by all Americans...
...The fact that it is now known universally as the Pfizer shot is “the biggest marketing coup in the history of American pharmaceuticals”....
...A version of this article was first published by Nikkei Asia on July 27. ©2022 Nikkei Inc. All rights reserved....
...But given PMI’s intention to partner with molecule-owners on inhaled therapies it needs to be able to win business in an ESG-focused world....
...Opioid overdoses have claimed the lives of more than 500,000 Americans over the past two decades....
...The letter was organised by Ken Chenault, former chief executive of American Express, and Ken Frazier, outgoing chief executive of Merck....
...‘Once bitten, twice shy’ Before the pandemic, Pfizer and Sanofi had both begun to dabble in mRNA vaccines through partnerships — but Pfizer’s partner BioNTech was far further along than Sanofi’s partner...
...“As a long-term partner to the US government in the fight against this pandemic, we are proud of the impact of vaccination efforts across the country....
...It contains an artificially produced recombinant protein, a common basis for many pharmaceuticals, which is derived from coronavirus....
...“As our vaccine supply for the American people is secured, the administration will continue to ramp up its efforts — working with the private sector and all possible partners — to expand vaccine manufacturing...
...His vice-president, Delcy Rodríguez, had just arrived back from Moscow bearing seasonal tidings of comfort and joy regarding Russia’s Sputnik V vaccine....
...Bastian says he was guided by conversations with Kenneth Frazier, retiring chief executive at pharmaceutical group Merck....
...“This African American man, who could be me or any other African American man, was being treated as less than human,” said Mr Frazier. For four days thereafter, state officials had done nothing....
...‘Perfect scenario’ Those look like V-shaped projections, Andrew Glenn thought to himself....
...Pfizer is at the phase III stage of trialling a vaccine candidate developed in conjunction with its German partner BioNTech....
International Edition